Subtopic Deep Dive
Artemisinin Resistance in Plasmodium falciparum
Research Guide
What is Artemisinin Resistance in Plasmodium falciparum?
Artemisinin resistance in Plasmodium falciparum refers to reduced parasite susceptibility to artemisinin-based therapies due to genetic mutations, particularly in the kelch13 propeller gene, threatening global malaria control.
Researchers identified C580Y and other kelch13 mutations as molecular markers of resistance in Cambodian field isolates (Ariey et al., 2013, 2075 citations). Resistance emerged on the Cambodia-Thailand border, with declining artesunate-mefloquine efficacy signaling early warnings (Wongsrichanalai and Meshnick, 2008, 311 citations). Over 10 papers in the provided list address markers, mechanisms, and surveillance, with genetic diversity studies aiding resistance tracking (Kidgell et al., 2006, 271 citations).
Why It Matters
Artemisinin-based combination therapies (ACTs) remain the cornerstone of malaria treatment, but kelch13 mutations drive resistance spread from Southeast Asia, risking resurgence as seen historically (Petersen et al., 2011). Surveillance of markers like those in Ariey et al. (2013) enables early detection, guiding policy shifts toward new candidates profiled by Burrows et al. (2017). Fitness costs of resistance, explored in genetic variation maps (Kidgell et al., 2006), inform containment strategies, while public health implications underscore monitoring to sustain elimination efforts (White, 1998).
Key Research Challenges
Spread Surveillance
Tracking kelch13 variants across endemic regions requires genomic surveillance amid genetic diversity (Kidgell et al., 2006). Resistance emergence on borders complicates containment (Wongsrichanalai and Meshnick, 2008). Over 2000 citations highlight persistent gaps in real-time monitoring (Ariey et al., 2013).
Fitness Cost Analysis
Mutations confer resistance but impose fitness costs, varying by genetic background (Petersen et al., 2011). Quantifying transmission advantages versus costs demands longitudinal studies. Systematic reviews link markers to outcomes but note heterogeneity (Picot et al., 2009).
Novel Drug Development
Declining ACT efficacy necessitates new candidates amid resistance mechanisms (Burrows et al., 2017). Molecular insights reveal targets, yet pipeline gaps persist (De Rycker et al., 2018). Public health threats from resistance amplify urgency (White, 1998).
Essential Papers
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frédéric Ariey, Benoît Witkowski, Chanaki Amaratunga et al. · 2013 · Nature · 2.1K citations
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows, Stephan Duparc, Winston E. Gutteridge et al. · 2017 · Malaria Journal · 516 citations
A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication. Changes in the way new anti-malarial drugs are discovered and...
The complexities of malaria disease manifestations with a focus on asymptomatic malaria
Dolie D Laishram, Patrick L Sutton, Nutan Nanda et al. · 2012 · Malaria Journal · 343 citations
Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border
Chansuda Wongsrichanalai, Steven R. Meshnick · 2008 · Emerging infectious diseases · 311 citations
Resistance to many antimalaria drugs developed on the Cambodia-Thailand border long before developing elsewhere. Because antimalaria resistance is now a global problem, artemisinin-based combinatio...
Genetic Diversity of<i>Plasmodium falciparum</i>Histidine‐Rich Protein 2 (PfHRP2) and Its Effect on the Performance of PfHRP2‐Based Rapid Diagnostic Tests
Joanne Baker, James McCarthy, Michelle L. Gatton et al. · 2005 · The Journal of Infectious Diseases · 309 citations
Rising costs of antimalarial agents are increasing the demand for accurate diagnosis of malaria. Rapid diagnostic tests (RDTs) offer great potential to improve the diagnosis of malaria, particularl...
Drug‐resistant malaria: Molecular mechanisms and implications for public health
Ines Petersen, Richard T. Eastman, Michael Lanzer · 2011 · FEBS Letters · 283 citations
Resistance to antimalarial drugs has often threatened malaria elimination efforts and historically has led to the short‐term resurgence of malaria incidences and deaths. With concentrated malaria e...
A Systematic Map of Genetic Variation in Plasmodium falciparum
Claire Kidgell, Sarah K. Volkman, Johanna P. Daily et al. · 2006 · PLoS Pathogens · 271 citations
Discovering novel genes involved in immune evasion and drug resistance in the human malaria parasite, Plasmodium falciparum, is of critical importance to global health. Such knowledge may assist in...
Reading Guide
Foundational Papers
Start with Ariey et al. (2013) for kelch13 marker discovery (2075 citations), then Wongsrichanalai and Meshnick (2008) for border emergence, and Petersen et al. (2011) for mechanisms to build core understanding.
Recent Advances
Study Burrows et al. (2017, 516 citations) for new drug profiles and De Rycker et al. (2018) for discovery challenges addressing resistance threats.
Core Methods
Kelch13 sequencing for mutations (Ariey et al., 2013); genetic diversity mapping (Kidgell et al., 2006); meta-analysis of marker-outcome links (Picot et al., 2009).
How PapersFlow Helps You Research Artemisinin Resistance in Plasmodium falciparum
Discover & Search
Research Agent uses searchPapers and exaSearch to query 'kelch13 mutations Plasmodium falciparum resistance', surfacing Ariey et al. (2013) as top hit with 2075 citations. citationGraph reveals spread from Wongsrichanalai and Meshnick (2008) to recent profiles like Burrows et al. (2017). findSimilarPapers expands to Petersen et al. (2011) for mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent to extract kelch13 data from Ariey et al. (2013), then verifyResponse with CoVe cross-checks mutation prevalence against Kidgell et al. (2006). runPythonAnalysis processes citation networks or genetic diversity stats via pandas for fitness correlations. GRADE grading scores evidence strength for surveillance claims (Picot et al., 2009).
Synthesize & Write
Synthesis Agent detects gaps in kelch13 fitness cost literature via contradiction flagging across Petersen et al. (2011) and White (1998). Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Ariey et al. (2013), with latexCompile generating figures and exportMermaid for resistance spread diagrams.
Use Cases
"Analyze fitness costs of kelch13 C580Y mutation from recent papers"
Research Agent → searchPapers('kelch13 fitness cost') → Analysis Agent → runPythonAnalysis(pandas on mutation frequencies from Ariey 2013 + Kidgell 2006) → statistical plot of transmission fitness output.
"Draft LaTeX review on artemisinin resistance surveillance"
Synthesis Agent → gap detection (Ariey 2013 vs Wongsrichanalai 2008) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → polished PDF review.
"Find code for Plasmodium genetic analysis in resistance papers"
Research Agent → paperExtractUrls(Kidgell 2006) → Code Discovery → paperFindGithubRepo → githubRepoInspect → downloadable scripts for SNP analysis in kelch13 variants.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ kelch13 papers: searchPapers → citationGraph → GRADE all claims → structured report on resistance spread from Ariey et al. (2013). DeepScan applies 7-step analysis with CoVe checkpoints to verify mutation-treatment correlations (Picot et al., 2009). Theorizer generates hypotheses on fitness costs by synthesizing Petersen et al. (2011) mechanisms with Burrows et al. (2017) profiles.
Frequently Asked Questions
What defines artemisinin resistance in Plasmodium falciparum?
Reduced ring-stage clearance due to kelch13 propeller gene mutations like C580Y, first marked in Ariey et al. (2013) from Cambodian isolates (2075 citations).
What methods detect resistance markers?
Sequencing kelch13 for propeller domain variants correlates with treatment failure, validated in meta-analyses (Picot et al., 2009). Field surveillance tracks spread as in Wongsrichanalai and Meshnick (2008).
What are key papers on this topic?
Foundational: Ariey et al. (2013, 2075 citations) on molecular marker; Petersen et al. (2011, 283 citations) on mechanisms. Early signal: Wongsrichanalai and Meshnick (2008, 311 citations).
What open problems remain?
Fitness costs of mutations vary by background (Kidgell et al., 2006); new drugs needed amid ACT decline (Burrows et al., 2017); global surveillance gaps persist (White, 1998).
Research Parasites and Host Interactions with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Artemisinin Resistance in Plasmodium falciparum with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Parasites and Host Interactions Research Guide